Sangamo Therapeutics said the Food and Drug Administration has cleared its investigational new drug application for its ST-400 treatment for intractable pain due to idiopathic small fiber neuropathy.

Your nervous system is a key force behind so many important bodily functions. But when your peripheral nerves—those found outside of the brain and spinal cord—are damaged, it can cause pain and ...

NORTH CHICAGO, IL, USA I 18, 2024 I AbbVie (NYSE: ABBV) today announced the European Commission (EC) granted marketing authorization for ELAHERE® ...

And these data are really quite interesting and impressive that if you don't progress and that your time on [enfortumab ...

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

University of Sheffield spinout company, Rinri Therapeutics, a company focused on developing new treatments for hearing loss ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis.

A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...

While it's common in your feet, your hands can also be effected by Neuropathy. Essential Neuropathy in Lee's Summit breaks ...

forging a new strategic alliance with the Inherited Neuropathy Consortium (INC) GLENOLDEN, PA / ACCESSWIRE / November 13, ...